First Sub-unit Tuberculosis Vaccine Shows Promise to Protect

The results from an innovative clinical trial provide new evidence that Tuberculosis (TB) vaccines could prevent sustained infections in high-risk adolescents. The trial has been conducted by Aeras, a nonprofit organization dedicated to developing vaccines against tuberculosis.
Email bookmark
Font : A-A+

Related Links